Article | March 9, 2021

High-Quality Chromatography System Meets Predesigned DeltaV For Integrated Manufacturing

Source: Cytiva

By Torbjörn Blank, Product Manager, and Mikael Björling, Automation Engineer, Cytiva

AKTA04

<p>Automation will drive optimization and connectedness throughout development and manufacturing, playing an essential role in the future of biopharma. Future-proofing your facility by implementing automated technologies that enable scale-up can enhance consistency and reliability and improve the quality of your drug product.</p> <p>However, there is a growing trend with drug manufacturers implementing full-scale automation to leave critical decisions about the system&#39;s and facility&#39;s key functionality to the engineering company configuring the distributed control system (DCS). Without bioprocessing knowledge, a third-party integrator could create a system that won&#39;t work in the best way.</p> <p>Cytiva has developed &Auml;KTA process DCS, a turnkey solution that combines proven industrial automation with a high-quality chromatography system. The system comes with a predefined automation software solution that applies Cytiva&rsquo;s process and equipment expertise to Emerson&rsquo;s DeltaV&trade; DCS platform.</p> <p>With the &Auml;KTA process DCS, Cytiva&rsquo;s automation experts collaborate with in-house application and process specialists to ensure they understand your needs and build a system with the critical functionality needed for every step in your process.</p>

access the Article!

Get unlimited access to:

Trend and Thought Leadership Articles
Case Studies & White Papers
Extensive Product Database
Members-Only Premium Content
Welcome Back! Please Log In to Continue. X

Enter your credentials below to log in. Not yet a member of Cell & Gene? Subscribe today.

Subscribe to Cell & Gene X

Please enter your email address and create a password to access the full content, Or log in to your account to continue.

or

Subscribe to Cell & Gene